Features
The growth in businesses utilising captives to tackle rising employee benefits costs is a relatively recent...
MORE
Henk Potts, Director, Global Investment Strategy at Barclays Wealth, discusses Europe's economic environment and captive...
MORE
Captive Review speaks to leading industry figures in Europe's biggest captive insurance domicile. Featuring contributions...
MORE
Clive James, group COO and managing director of EMEA at Kane, discusses why cell business...
MORE
Mark Helyar, partner at Bedell Cristin, discusses his firm's role in the captive insurance industry and...
MORE
Chris Le Conte, managing director of Robus Group, discusses cell structures and the growth Guernsey...
MORE
Dominic Wheatley, CEO of Guernsey Finance, discusses the jurisdiction's status within the captive insurance industry...
MORE
Mark Helyar, of Bedell Cristin, Kane's Clive James and Chris Le Conte, of Robus Group,...
MORE
Paul Sykes, Chairman of the Guernsey International Insurance Association, discusses developments in Guernsey and the...
MORE
Jamie Polson, director of Robus Risk Services in Guernsey, discusses the strengths of the jurisdiction...
MORE

John Keating joins Coca-Cola European Partners

John Keating has joined the risk and insurance team at Coca-Cola European Partners (CCEP) as associate director, risk...
MORE

Hong Kong has captive potential, but tax changes not a “game changer”

The tax changes tipped to encourage captive formations in Hong Kong is unlikely to have the desired effect, according to Jonathan Culver, leader of Deloitte’s financial services tax...
MORE

Three captives in, 29 out of BVI

The British Virgin Islands licensed three new captives in 2017, while 29 captives surrendered their licence. The high number of surrendered licences follows a trend across offshore and...
MORE

Pfizer captive rated ‘Excellent’

The Vermont captive owned by pharmaceutical giant Pfizer has had its financial strength rating of ‘A’ (Excellent) affirmed by A.M. Best. Blue Whale Re Ltd writes Pfizer’s global...
MORE